Powell M - Search Results

1

A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer.

Vergote I, Heitz F, Buderath P, Powell M, Sehouli J, Lee CM, Hamilton A, Fiorica J, Moore KN, Teneriello M, Golden L, Zhang W, Pitou C, Bell R, Campbell R, Farrington DL, Bell-McGuinn K, Wenham RM. Vergote I, et al. Among authors: powell m. Gynecol Oncol. 2020 Jan;156(1):23-31. doi: 10.1016/j.ygyno.2019.11.006. Epub 2019 Nov 29. Gynecol Oncol. 2020. PMID: 31791552 Clinical Trial.

2

Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.

Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, Modesitt SC, Lu KH, Geisler JP, Higgins RV, Magtibay PM, Cohn DE, Powell MA, Chu C, Stehman FB, van Nagell J. Schilder JM, et al. Among authors: powell ma. Gynecol Oncol. 2002 Oct;87(1):1-7. doi: 10.1006/gyno.2002.6805. Gynecol Oncol. 2002. PMID: 12468335

3

Adequate staging for uterine cancer can be performed through Pfannenstiel incisions.

Horowitz NS, Powell MA, Drescher CW, Smith MR, Atwood M, Mate TA, Peters WA. Horowitz NS, et al. Among authors: powell ma. Gynecol Oncol. 2003 Mar;88(3):404-10. doi: 10.1016/s0090-8258(02)00166-x. Gynecol Oncol. 2003. PMID: 12648594

4

Synchronous ovarian metastases at the time of laparotomy for colon cancer.

Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Huettner PC, Herzog TJ. Wright JD, et al. Gynecol Oncol. 2004 Mar;92(3):851-5. doi: 10.1016/j.ygyno.2003.12.017. Gynecol Oncol. 2004. PMID: 14984952

5

Resource utilization for ovarian cancer patients at the end of life: how much is too much?

Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, Herzog TJ. Lewin SN, et al. Among authors: powell ma. Gynecol Oncol. 2005 Nov;99(2):261-6. doi: 10.1016/j.ygyno.2005.07.102. Epub 2005 Sep 2. Gynecol Oncol. 2005. PMID: 16140364

6

Carcinosarcoma of the ovary-a case series.

Rutledge TL, Gold MA, McMeekin DS, Huh WK, Powell MA, Lewin SN, Mutch DG, Johnson GA, Walker JL, Mannel RS. Rutledge TL, et al. Gynecol Oncol. 2006 Jan;100(1):128-32. doi: 10.1016/j.ygyno.2005.07.119. Epub 2005 Oct 5. Gynecol Oncol. 2006. PMID: 16213011

7

Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.

Wright JD, Viviano D, Powell MA, Gibb RK, Mutch DG, Grigsby PW, Rader JS. Wright JD, et al. Gynecol Oncol. 2006 Nov;103(2):489-93. doi: 10.1016/j.ygyno.2006.03.023. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16647106

8

CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan.

Gossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ. Gossner G, et al. Gynecol Oncol. 2006 Oct;103(1):212-8. doi: 10.1016/j.ygyno.2006.02.026. Epub 2006 May 3. Gynecol Oncol. 2006. PMID: 16677696

9

Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.

Herzog TJ, Powell MA, Rader JS, Gibb R, Mutch DG. Herzog TJ, et al. Gynecol Oncol. 2006 Nov;103(2):637-41. doi: 10.1016/j.ygyno.2006.04.014. Epub 2006 Jun 15. Gynecol Oncol. 2006. PMID: 16781766 Clinical Trial.

10

External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.

Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. Lin LL, et al. Gynecol Oncol. 2007 Jul;106(1):215-20. doi: 10.1016/j.ygyno.2007.03.024. Epub 2007 May 7. Gynecol Oncol. 2007. PMID: 17482665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,084 results

Search Page